News
Liver cancer could hit you sooner than you think. In an interview with HT Lifestyle, Dr Amar Mukund, Professor and Head of ...
1d
Sportschosun on MSNImmune anticancer drug treatment failure Progressive hepatocellular carcinoma improves survival rate with classical treatmentTwo international academic journals have found that it is effective to apply classical treatments to patients with advanced ...
As India marks World Liver Day, health experts are raising concerns over the rising burden of liver cancer, a disease often ...
The fig summarizes the main treatment strategies for HCC. Hepatocellular carcinoma (HCC) is the most prevalent form of liver ...
Liver cancer, particularly hepatocellular carcinoma (HCC), has become a major health concern in Uganda. The Uganda Cancer ...
Hepatocellular carcinoma (HCC) is a leading cause of cancer-related deaths worldwide, with over 70% of patients diagnosed at ...
The combination therapy can be used as first-line treatment for unresectable or metastatic forms of the cancer.
Mursla Bio, a Cambridge UK and Boston US leader in Extracellular Vesicle (EV) science, has received FDA approval for its lead ...
The Food and Drug Administration (FDA) has approved Opdivo ® (nivolumab) in combination with Yervoy ® (ipilimumab) for the first-line treatment of adult patients with unresectable or metastatic ...
Outcomes for advanced hepatocellular carcinoma with pulmonary metastasis: Surgical vs. immunotherapy
Advanced hepatocellular carcinoma (HCC) with pulmonary metastasis (PM) has a poor prognosis, and optimal treatment strategies remain controversial. This study compared pulmonary metastasectomy and ...
Unable to secure additional financing amid a stormy market, Tempest Therapeutics has put a call out for partners as it seeks ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results